IP Library Granted Patent US 11,013,527
Granted Patent B1
US 11,013,527 · App. 17/177,271 · Granted May 25, 2021

Cellulite treatment system and methods

Inventors: Jonathan Podmore (San Carlso, CA); Earl Bright, II (Sunnyvale, CA); Joshua Makower (Los Altos Hills, CA); John Hanley (Manhattan Beach, CA); Pablo Acosta (Newark, CA); Theodore Ketai (Chico, CA); William Sauway Law (Palo Alto, CA); Michael Schaller (Louisville, CO); Bryan Hartley (Redwood City, CA)
Assignee: NC8, Inc.
A61B17/320016A61B1/06A61B2017/00747A61B2017/00792
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,013,527
App. No.
17/177,271
Granted
May 25, 2021
Kind
B1
Abstract

Systems and methods for treating cellulite including an apparatus that applies or a method involving separating septa to eliminate or reduce the appearance of cellulite. In one approach, an interventional tool is placed between tissue layers to engage and treat septa connecting tissue layers between which fat deposits are contained.

Claims (31)

1. A method involving a cellulite treatment system for treating expressions of cellulite on a patient's skin associated with a septa treatment site, comprising:

gaining access to a location between tissue layers connected by septa;

advancing the cellulite treatment system, having a mechanical septa disrupting element that cooperates with a septa hooking element, to a target site;

deploying the septa hooking element to a first position, which shields the septa disrupting element;

engaging selected septa to determine if the selected septa are associated with an expression of cellulite;

transitioning the septa hooking element to a second position to expose the septa disrupting element; and

separating certain of the selected septa that are associated with the expression of cellulite.

2. The method of claim 1 , further comprising creating a treatment regimen involving using a same insertion site to treat multiple areas.

3. The method of claim 2 , wherein the insertion site is located in a crease or fold in the skin when the buttocks are in a natural position.

4. The method of claim 3 , wherein the insertion site is located in the crease where the buttock meets the thigh.

5. The method of claim 1 , wherein the septa hooking element operates to tension selected septa.

6. The method of claim 1 , further comprising employing transillumination to track positioning of the cellulite treatment device between tissue layers.

7. The method of claim 6 , further comprising utilizing transillumination brightness or size of the illuminated spot on the skin to adjust the depth of a tip of the cellulite treatment system.

8. The method of claim 1 , further comprising providing the cellulite treatment system with a shaft sized and shaped to be inserted within tissue and to be advanced between the tissue layers to a septa treatment site without assistance from tissue stabilizing structure applied to the patient's skin.

9. The method of claim 1 , wherein the mechanical septa disrupting element includes a cutting structure, further comprising manipulating the cutting structure to cut or slice certain of the selected septa connecting tissue layers.

10. The method of claim 1 , further comprising scanning skin of a subject to identify treatment areas and create a treatment regimen and a scanning data, the scanning data being stored within a computerized controller so that the efficacy of a treatment can be assessed.

11. The method of claim 1 , further comprising employing a tube to remove a section of septa.

12. The method of claim 1 , further comprising providing a plurality of cellulite treatment devices, combining the devices into a combined single assembly, and conducting a cellulite treatment procedure with the combined single assembly.

13. The method of claim 1 , further comprising confirming that the certain of the selected septa that are associated with the expression of cellulite are separated.

14. The method of claim 1 , further comprising, if septa remain intact that are associated with the expression of cellulite, engaging additional selected septa to determine if the additional selected septa area associated with an expression of cellulite; and

separating certain of the additional selected septa that are associated with the expression of cellulite.

15. The method of claim 1 , further comprising:

advancing the septa hooking element in an undeployed position beyond the targeted site;

wherein the engaging step comprises deploying the septa hooking element and pulling proximally to tension the septa.

16. The method claim 15 , further comprising advancing the septa hooking element in an undeployed position about 1 to about 10 millimeters lateral of the targeted site.

17. The method of claim 16 , further comprising advancing the septa hooking element in an undeployed position about 3 to about 6 millimeters lateral of the targeted site.

18. The method of claim 1 , wherein the step of determining whether the engaged selected septa are associated with the expression of cellulite compromises pulling on the selected septa and visualizing whether a depression is formed on the skin at the target site.

19. The method of claim 18 , further comprising:

after the septa that are associated with the expression of cellulite have been separated, moving the mechanical septa disrupting element and the septa hooking element back to the undeployed position;

advancing the septa hooking element in an undeployed position beyond the targeted site; and

deploying the septa hooking element and pulling proximally under the targeted site to confirm that all of the septa responsible for the expression of cellulite in the targeted site have been separated.

Assignments (2)
SECURITY INTEREST Recorded May 31, 2023
From: REVELLE AESTHETICS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 063803/0159 →
CHANGE OF NAME Recorded Jul 19, 2021
From: NC8, INC.
To: REVELLE AESTHETICS, INC
Reel/Frame 056907/0642 →
Continuity (7)
Continuation 17154232 · Jan 21, 2021
Continuation In Part PCTUS2019042871 · Jul 22, 2019
Provisional Application 62702314 · Jul 23, 2018
Provisional Application 62736016 · Sep 25, 2018
Provisional Application 62798515 · Jan 30, 2019
Provisional Application 62802368 · Feb 7, 2019
Provisional Application 62825447 · Mar 28, 2019
Cited By (4)
US 12,527,594 US 12,527,597 US 12,588,923 US 12,702,473